Hallgasd meg ezt a podcastot: Evaluating Biopharma

Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance	Evaluating Biopharma	16:49
Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech	Evaluating Biopharma	35:01
Episode: 21 - How AI is Changing the Antibody R&D Game	Evaluating Biopharma	31:35
Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix	Evaluating Biopharma	19:38
Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies	Evaluating Biopharma	17:20
Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts	Evaluating Biopharma	23:56
Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin	Evaluating Biopharma	22:56
Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma	Evaluating Biopharma	21:21
Episode: 15 - Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa	Evaluating Biopharma	19:42
Episode: 14 - Strategies and Approaches for Process Intensification With Dr. Stefan Schmidt	Evaluating Biopharma	16:08
Episode: 13 - Identifying Impurities In Gene Therapy With Santoshkumar Khatwani	Evaluating Biopharma	19:38
Episode: 12 - The Risks and Rewards of Speed-to-IND Strategies With Susan Jones	Evaluating Biopharma	19:32
Episode: 11 - Cell Therapy Strategies: Preparing for Commercial Manufacturing of an Autologous Cell Therapy	Evaluating Biopharma	21:49
Episode: 10 - Gene Therapy Analytics: How to Make the Right CMC Investments for Your Business	Evaluating Biopharma	22:43
Episode: 9 - Gene Therapy Analytics: Identifying and Overcoming CMC Challenges in Gene Therapy	Evaluating Biopharma	24:32
Episode: 8 - The Financial Impact of a Continuous Bioprocessing Strategy	Evaluating Biopharma	20:08
Episode: 7 - Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy	Evaluating Biopharma	27:22
Episode: 06 - Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing	Evaluating Biopharma	19:15
Episode: 05 - Navigating Scale-Up Challenges in Protein Production	Evaluating Biopharma	20:45
Episode 4: Anticipating Disruptions: Identifying and Planning for Shortages	Evaluating Biopharma	19:42
Episode: 3 - Cell and Gene Therapy: Managing the ‘Build or Buy’ Decision	Evaluating Biopharma	22:36
Episode: 2 - Operational Efficiencies: Lower Operational Costs by Reducing Clinical GMP Sampling	Evaluating Biopharma	25:12
Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection	Evaluating Biopharma	21:53
Episode 000: Introducing the Evaluating Biopharma Podcast	Evaluating Biopharma	02:07

Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance

Evaluating Biopharma

16:49

Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech

Evaluating Biopharma

35:01

Episode: 21 - How AI is Changing the Antibody R&D Game

Evaluating Biopharma

31:35

Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix

Evaluating Biopharma

19:38